4.7 Article

Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1

Journal

JOURNAL OF CELL BIOLOGY
Volume 162, Issue 6, Pages 1089-1098

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200212060

Keywords

LIM kinase 1; BMPR-II; cytoskeleton; F-actin; cofilin

Categories

Funding

  1. NCI NIH HHS [R01 CA034610, R37 CA034610, CA34610] Funding Source: Medline

Ask authors/readers for more resources

Bone morphogenetic proteins (BMPs) regulate multiple cellular processes, including cell differentiation and migration. Their signals are transduced by the kinase receptors BMPR-I and BMPR-II, leading to Smad transcription factor activation via IMPR-I. LIM kinase (LIMK) 1 is a key regulator of actin dynamics as it phosphorylates and inactivates cofilin, an actin depolymerizing factor. During a search for LIMK1-interacting proteins, we isolated clones encompassing the tail region of BMPR-II. Although the BMPR-II tail is not involved in BMP signaling via Smad proteins, mutations truncating this domain are present in patients with primary pulmonary hypertension (PPH). Further analysis revealed that the interaction between LIMK1 and BMPR-II inhibited LIMK1's ability to phosphorylate cofilin, which could then be alleviated by addition of BMP4. A BMPR-II mutant containing the smallest COOH-terminal truncation described in PPH failed to bind or inhibit LIMK1. This study identifies the first function of the BMPR-II tail domain and suggests that the deregulation of actin dynamics may contribute to the etiology of PPH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available